Skip to main content

Table 1 Source studies

From: Statin cost effectiveness in primary prevention: A systematic review of the recent cost-effectiveness literature in the United States

Study, 1st Author

Year

Population

Drug Studied

Time Horizon

Outcome Measured

Prosser LA

2000

Age 35-84, LDL >159

Pravastatin

30 years

QALY

Caro JJ

2003

Age >45

Pravastatin

5 years

LYG

Pignone M

2006

45-year old men

Pravastatin

Lifetime

QALY

Pletcher MJ

2009

Age >35

All statins

30 years

QALY

  1. Methodological differences among studies. QALY, quality adjusted life year; LYG, life year gained; LDL, low density lipoprotein cholesterol.